Objective-The goal of this study was to assess the role of B-cell activating factor (BAFF) receptor in B-cell regulation of atherosclerosis. Methods and Results-Male LDL receptor-deficient mice (Ldlr −/− ) were lethally irradiated and reconstituted with either wild type or BAFF receptor (BAFF-R)-deficient bone marrow. After 4 weeks of recovery, mice were put on a high-fat diet for 6 or 8 weeks. BAFF-R deficiency in bone marrow cells led to a marked reduction of conventional mature B2 cells but did not affect the B1a cell subtype. This was associated with a significant reduction of dendritic cell activation and Tcell proliferation along with a reduction of IgG antibodies against malondialdehyde-modified low-density lipoprotein. In contrast, serum IgM type antibodies were preserved. Interestingly, BAFF-R deficiency was associated with a significant reduction in atherosclerotic lesion development and reduced numbers of plaque T cells. Selective BAFF-R deficiency on B cells led to a similar reduction in lesion size and T-cell infiltration but in contrast did not affect dendritic cell activation. 
A therosclerosis is an inflammatory disease of the arterial wall driven by innate and adaptive immune responses to a variety of endogenous agents; the most studied ones being lipoproteins and heat shock proteins. [1] [2] [3] [4] Several inflammatory cell subsets have been shown to promote atherosclerosis, including monocytes/macrophages, neutrophils, mast cells, and T lymphocytes. A notable exception was the proposed atheroprotective role of the B lymphocyte subset. 5, 6 However, these concepts have been refined during the last few years. For example, we and others have clearly shown that not all T lymphocytes are proatherogenic and have pinpointed T-cell regulatory subsets with potent antiatherogenic properties. [7] [8] [9] More recently, we reconsidered the role of B lymphocytes in atherosclerosis. We clearly showed that contrary to expectations based on previous studies, 5, 6 depletion of mature B cells in mice reduces lesion development, indicating the presence of a proatherogenic B-cell subset. 10 These results have been confirmed by another group of investigators 11 and have important consequences to our understanding of the immune response of atherosclerosis and the identification of suitable targets for disease modulation. A brief review of the previous and recent work on the role of B cells in atherosclerosis indicates that the proatherogenic effect is mainly driven by the common B2 subset, which responds to T-cell-dependent antigens and is part of the adaptive immune response. 10, 11 In contrast, the atheroprotective effect is mostly attributed to the minor innate B1a subset, which responds to T-cell-independent antigens and is responsible for the production of natural IgM antibodies. 12, 13 This protective property may largely depend on the capacity of natural IgM to recognize oxidation-specific epitopes on oxidized low-density lipoprotein (LDL) and cellular debris.
14 However, a recent study has shown that B cell homing to atherosclerotic lesions might be important for the atheroprotective effects of B cells, independently of IgM levels. 15 Thus, more work is still needed to fully capture the multiple roles of B-cell subtypes in atherosclerosis.
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Interestingly, the development, survival, proliferation, and functions of the various B-cell subsets are driven by distinct factors. One important factor is B-cell activating factor (BAFF), a member of the tumor necrosis factor family. 16 BAFF is produced both by hematopoietic and nonhematopoietic cells, and signals through 3 different receptors. BAFF is required for B cell maturation beyond the transitional T1 stage and supports the survival of low-affinity self-reactive B cells. As such, BAFF is involved in a variety of autoimmune-mediated diseases, and therapeutic strategies that interrupt its signaling pathways are currently approved or being tested in several clinical trials. 16 The survival role of BAFF on the B2-cell subset is mediated through BAFF receptor (BAFF-R), mostly expressed on mature B cells. 16 Mice deficient for BAFF-R show impaired B-cell maturation beyond the transitional T1 stage and therefore marked depletion of mature B2 cells. However, the B1 cell subset does not require BAFF-R signaling for its survival and is preserved in BAFF-R-deficient mice. 16, 17 We therefore hypothesized that inhibition of BAFF-R signaling would reduce B2 proatherogenic activity while preserving B1 atheroprotective potential, thereby limiting lesion development.
Methods
We used male Ldlr −/− and BAFF-R −/− mice on C57Bl/6 background. Details of Methods can be found in the online-only Data Supplement.
Results
In order to test this hypothesis, we subjected male Ldlr −/− mice to lethal total body irradiation followed by reconstitution with either wild type or BAFF-R −/− bone marrow (see Methods in the online-only Data Supplement). The mice were put on a high fat diet for 6 weeks to address the role of BAFF-R in immune responses and lesion development in the context of Figure 1C) . Interestingly, serum levels of total or antimalondialdehyde-LDL IgM antibodies were not altered by BAFF-R deficiency ( Figure 1C and data not shown), a finding consistent with the preservation of B1a cells that are responsible for serum levels of natural IgM antibodies, shown to be atheroprotective. 12, 18 In a previous study from our group, 10 we reported an important impact of mature B-cell depletion on dendritic cell (DC) activation and T-cell proliferation. In the present study, we also found a significant reduction of DC activation in mice reconstituted with BAFF-R −/− bone marrow, as exemplified by the reduction of CD40 and MHC-II expression on CD11c+DCs ( Figure IV in the online-only Data Supplement). BAFF-R deficiency was also associated with a marked reduction of T-cell activation ( Figure 1D ) and T-effector cell proliferation ( Figure 1E Finally, we addressed the effect of BAFF-R deficiency on the development of atherosclerotic lesions. As shown in Figure  2A , quantification of intimal area in the aortic root after Oil red O staining at 6 weeks of high-fat diet revealed a significant bone marrow compared with controls. Interestingly, BAFF-R deficiency was also associated with a reduction of lesion inflammation, as revealed by the significant decrease of total macrophage accumulation (MOMA2 staining) in the aortic root ( Figure 2B ) and a trend toward decreased ratio of MOMA2 staining to total lesion area (0.59±0.29 versus 0.84±0.35, P=0.11). The reduction of lesion size in mice reconstituted with BAFF-R −/− bone marrow was also significant after 8 weeks on high-fat diet (Figure 2A) 19 which is in agreement with the present results. Our studies on the mixed μMT/ BAFF-R chimeras also show that BAFF-R expression on B cells is sufficient to drive T-cell activation and atherogenesis, which is a unique and novel aspect. In addition, and in contrast to BAFF-R deficiency in total bone marrow-derived cells, DC activation is not altered in mice with selective BAFF-R deficiency in B cells. These results indicate that BAFF-R signaling in B cells directly drives T-cell activation/proliferation and atherosclerosis independently of DC activation. Finally, our results clearly suggest that blockade of BAFF-R signaling may constitute an interesting therapeutic strategy to limit the development of atherosclerosis, particularly in patients with associated BAFF-dependent immune-mediated diseases.
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None. ). After 4 wk of recovery, they were fed a high-fat diet (HFD) for 6 or 8 wk. A, Quantitative analysis of intimal lesion area at the aortic root on Oil red O-stained sections. B, Quantitative analysis of macrophage area at the aortic root on MOMA2-stained sections. C, Quantitative analysis of T-cell numbers at the aortic root on CD3-stained sections. *P<0.05.
